US 12116343
Inhibitors of APOL1 and methods of using same
granted A61KA61K31/404A61K31/496
Quick answer
US patent 12116343 (Inhibitors of APOL1 and methods of using same) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K31/404, A61K31/496, A61K31/5377, A61P